Tag: pharmacokinetics
World ADC 2019: Maximizing the Clinical Therapeutic Index of Antibody-drug Conjugates
With five approved and commercially available antibody-drug conjugates and nearly 100 in various stages of clinical development, it is exciting to see how the...
Computational exploration of Mechanistic Determinants of Antibody-drug Conjugate Pharmacokinetics
Applied BioMath, an industry-leader in applying mechanistic modeling to drug research and development to help biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in their...
A Chemistry Driven Approach to Uniform Antibody-drug Conjugates: New Data on...
Earlier today, during a plenary session of the 2015 World ADC Summit, being held October 26-29, 2014 in San Diego, California, Randall Halcomb, PhD, Vice President Chemistry at Igenica Biotherapeutics,
presented new data utilizing the company's SNAP site-specific ADC linker technology.
